Health Indicator Report of Childhood Immunizations
Immunizations are the one of most cost-effective health prevention measures. Development of vaccinations was cited by the U.S. Public Health Service as one of the [https://www.cdc.gov/mmwr/preview/mmwrhtml/00056796.htm Ten Great Public Health Achievements in the 20th Century]. Vaccines play an essential role in reducing and eliminating disease.
NotesThis is Healthy New Jersey 2020 (HNJ2020) objective IMM-1. [[br]]Obj. IMM-1a: Four (4) doses diphtheria-tetanus-acellular pertussis (DTaP) vaccine by 19-35* months of age [[br]]Obj. IMM-1b: Birth dose of hepatitis B vaccine (0-3 days between birth date and date of vaccination, reported by annual birth cohort) [[br]]Obj. IMM-1c: Four (4) doses of pneumococcal conjugate vaccine (PCV) among children by age 19-35* months of age *Beginning in 2018, data reflect the proportion of children who are up-to-date by 24 months of age. For 2010-2017, it was by 19-35 months of age. **2019 data unavailable.
Data Source[https://www.cdc.gov/vaccines/imz-managers/nis/index.html National Immunization Survey], National Center for Health Statistics, U.S. Centers for Disease Control and Prevention
DefinitionPercentage of young children who received effective vaccination coverage levels for universally recommended vaccines by a given age
NumeratorNumber of children of a given age* who received the recommended doses of universally recommended vaccines (*19 to 35 months of age (2010-2017) or 24 months of age (2018-2020) for all except Hepatitis B birth dose between 0 and 3 days old)
DenominatorTotal number of children of a given age* (*19 to 35 months of age (2010-2017) or 24 months of age (2018-2020) for all except Hepatitis B birth dose between 0 and 3 days old)
Healthy People Objective: Increase the proportion of children aged 19 to 35 months who receive the recommended doses of DTaP, polio, MMR, Hib, hepatitis B, varicella and PCV vaccinesU.S. Target: 80 percent
State Target: 80 percent
Other Objectives'''Healthy New Jersey 2020 Objective IMM-1''': Increase effective vaccination coverage levels for universally recommended vaccines among young children:[[br]] '''IMM-1a''': Four (4) doses diphtheria-tetanus-acellular pertussis (DTaP) vaccine by age 19 to 35 months (2010-2017) or 24 months (2018-2020) to 95%.[[br]] '''IMM-1b''': Birth dose of hepatitis B vaccine (0 to 3 days between birth date and date of vaccination, reported by annual birth cohort) to 75%.[[br]] '''IMM-1c''': Four (4) doses of pneumococcal conjugate vaccine (PCV) among children by age 19 to 35 months (2010-2017) or 24 months (2018-2020) to 90%. '''Healthy New Jersey 2020 Objective IMM-2''': Increase the percentage of children aged 19 to 35 months (2010-2017) or 24 months (2018-2020) who receive the recommended doses of DTaP, polio, MMR, Hib, hepatitis B, varicella and pneumococcal conjugate vaccine (PCV) to 80%.[[br]] Recommended doses are: 4 DTaP, 3 Polio, 1 MMR, full series of Hib (3 or 4 doses depending on type), 3+ HepB, 1+ Var, and 4+ PCV.
How Are We Doing?The coverage rate for the hepatitis B vaccination birth dose doubled between 2010 and 2020 while the DTaP and PCV vaccination coverage rates did not change much during the decade. The proportion of children in the U.S. and in New Jersey who received the recommended doses of DTaP, polio, MMR, Hib, hepatitis B, varicella, and pneumococcal conjugate vaccine (PCV) was fairly constant between 2011 and 2020.
How Do We Compare With the U.S.?New Jersey's coverage rate for the full recommended vaccine series is about the same as that of the nation as a whole.
What Is Being Done?The New Jersey Department of Health's [https://www.state.nj.us/health/cd/vpdp.shtml Vaccine Preventable Disease Program] (VPDP) conducts annual assessments of the immunization status for children attending licensed preschools/daycares and schools. The VPDP collaborates with immunization partners, provides education, and supports various immunization initiatives and campaigns at the state and local level. The following are some examples of VPDP activities to promote timely immunizations, increase immunization coverage rates, and reduce immunization access barriers: *Maintains the New Jersey [https://www.state.nj.us/health/cd/documents/vpdp/vfc_brochure.pdf Vaccines For Children] (VFC) Program, a federally funded, state-operated vaccine supply program that provides pediatric vaccines at no cost to doctors who serve children who might not otherwise be vaccinated because of inability to pay. *Partners with 77 Federally Qualified Health Centers and 63 Local Health Departments to provide immunizations services for those who meet the VFC Program eligibility criteria of being either Medicaid eligible, NJ FamilyCare insured, uninsured, or underinsured. *Supports state and municipality-focused immunization coalitions to provide education and outreach to immunization stakeholders and the public in an effort to increase awareness of the importance of immunization and immunization coverage rates. *Promotes quality improvement by including the use of the [https://www.nj.gov/health/cd/documents/vpdp/ped_and_adolescent_imm_standards.pdf Pediatric and Adolescent Immunization Standards Job Aid] in identifying barriers that impede vaccine delivery and missed opportunities by way of improving provider immunization policies and practices. *Tracks statewide immunization coverage through the official statewide immunization registry, NJ Immunization Information System (NJIIS), which provides a mechanism for medical providers to keep track of patient immunizations, and to send reminder cards/letters to NJ parents whose children are due for immunizations. NJIIS also archives adult immunizations such as pneumovax, tetanus, diphtheria and acellular pertussis (TdaP); influenza; smallpox; Human Papillomavirus Vaccine (HPV), Hepatitis A and B, and COVID-19.
Page Content Updated On 05/04/2022, Published on 07/15/2022